Sirtuins在配子生物学与生殖生理中的作用:在女性和男性不孕中的新兴角色与治疗潜力
本综述更新Sirtuins(SIRT1-7)在雌雄生殖生理与病理中的作用,检索MEDLINE原创论文。多数研究聚焦SIRT1且以女性生殖为主;SIRT1下调与卵巢储备生理性或病理性降低相关,SIRT3促进黄体化;SIRT1/2/3/6改善卵母细胞体外成熟能力,SIRT1/2/3保护卵母细胞免受排卵后老化;SIRT1参与精子发生,母源SIRT3保护早期胚胎;提高SIRT1活性可能改善PCOS、糖尿病、子宫内膜异位症、外源物应激和衰老相关不孕。
要点
- SIRT1下调与生理性或病理性卵巢储备降低相关,SIRT3促进黄体化。
- SIRT1、SIRT2、SIRT3和SIRT6的生化调控可改善人及动物模型体外生长或成熟卵母细胞的潜能。
- 提高SIRT1活性可能改善PCOS、糖尿病、子宫内膜异位症、外源物应激和衰老相关的不孕。
核心结论
- Sirtuins在雌雄生殖中作用广泛,SIRT1活性提升可能改善PCOS、糖尿病、子宫内膜异位症、外源物应激和衰老相关不孕,Sirtuin信号可作为诊断工具和治疗靶点。
研究设计与样本
- 本综述检索MEDLINE同行评议原创论文,关键词包括Sirtuin、卵巢、卵母细胞、卵泡、胚胎、子宫内膜、精子、睾丸及相关短语。
主要发现
- 多数研究聚焦SIRT1且以女性生殖为主;SIRT1下调与生理性或病理性卵巢储备降低相关。
- SIRT1调控颗粒细胞增殖与凋亡,SIRT3促进黄体化。
- SIRT1、SIRT2、SIRT3和SIRT6的生化调控改善人及动物模型体外生长或成熟卵母细胞的潜能。
- SIRT1、SIRT2和SIRT3保护卵母细胞免受排卵后老化;SIRT1通过影响雄性生殖细胞、支持细胞和间质细胞参与精子发生;母源SIRT3保护早期胚胎应激。
- 提高SIRT1活性可能改善PCOS、糖尿病、子宫内膜异位症、外源物应激和衰老相关不孕,效应归因于能量稳态、线粒体生物合成、染色质重塑和氧化应激保护。
关键数值与推荐
- SIRT1下调与生理性或病理性卵巢储备降低相关;SIRT3促进黄体化。
- SIRT1、SIRT2、SIRT3和SIRT6改善人及动物模型体外生长或成熟卵母细胞的潜能。
- SIRT1、SIRT2和SIRT3保护卵母细胞免受排卵后老化。
- 母源SIRT3保护早期胚胎免受应激;提高SIRT1活性可能改善PCOS、糖尿病、子宫内膜异位症、外源物应激和衰老相关不孕。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出近期缺乏关于Sirtuins在生殖生物学中作用的全面更新。
- 原文指出多数工作聚焦SIRT1且以女性生殖研究为主。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sirtuins (SIRT1-7) are a family of NAD+-dependent deacetylases that catalyze post-translational modifications of proteins. Together, they respond to metabolic challenges, inflammatory signals or hypoxic/oxidative stress, and are associated with aging and longevity. The role of Sirtuins in the regulation of fertility emerged in 2003 when a defective reproductive phenotype was observed in SIRT1-null mice. Although studies on Sirtuins in reproductive biology have been increasing in the last years, a recent comprehensive update on this issue is still lacking. OBJECTIVE AND RATIONALE: This review is aimed to provide knowledge on the activation mechanism and cellular role of Sirtuins and to give an update of the rapid development of Sirtuin research in female and male reproduction under physiological and pathological conditions. The final goal is to assess whether strategies aimed to improve Sirtuin expression or activity could have therapeutic potential for infertility associated with polycystic ovarian syndrome (PCOS), endometriosis, diabetes, xenobiotic stress and aging. SEARCH METHODS: The MEDLINE database was examined for peer-reviewed original articles. The following keywords were searched: 'Sirtuin', 'ovary', 'oocyte', 'ovarian follicle', 'embryo', 'endometrium', 'sperm' and 'testis'. These keywords were combined with other search phrases relevant to the topic. OUTCOMES: Our knowledge of Sirtuins in reproductive functions has grown exponentially over the last few years. The majority of the work carried out so far has focused on SIRT1 with a prevalence of studies on female reproduction. Numerous studies have provided evidence that down-regulation of SIRT1 is associated with physiological or pathological reduction of ovarian reserve. SIRT1 has also been shown to regulate proliferation and apoptosis in granulosa cells whereas SIRT3 was found to promote luteinisation. Biochemical modulation of Sirtuin activity has led to discoveries of the roles of SIRT1, SIRT2, SIRT3 and SIRT6 in improving the competence of oocytes grown or matured in vitro in humans and animal models. Recently, SIRT1, SIRT2 and SIRT3 have emerged as protectors of oocyte against postovulatory aging. Transgenic models provide strong evidence that SIRT1 is involved in spermatogenesis by influencing specific functions of male germ cell, Sertoli cells and Leydig cells. When our attention moves to post-fertilization events, maternally derived SIRT3 appears crucial in the protecting early embryos against stress conditions. Finally, increasing SIRT1 activity may have the potential to ameliorate fertility in PCOS, diabetes, endometriosis, xenobiotic stress and aging. Overall, these effects have been ascribed to Sirtuin-mediated regulation of energy homoeostasis, mitochondrial biogenesis, chromatin remodelling and protection against oxidative stress. WIDER IMPLICATIONS: The present review provides challenges and opportunities to stimulate research and exploit Sirtuin-based signalling as diagnostic tools and potential targets for therapeutic applications in reproductive medicine.
引用
- Tatone C, Di Emidio G, Barbonetti A, et al. Sirtuins in gamete biology and reproductive physiology: emerging roles and therapeutic potential in female and male infertility. Hum Reprod Update. 2018. PMID: 29447380. doi:10.1093/humupd/dmy003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。